How to Get GLP-1 Patients as a Prescriber in North Carolina

You’re already seeing it in your practice: patients gaining 30, 40, 50 pounds on their psych meds. The apologetic comments about diets that stopped working. The requests to switch medications even when they’re finally stable, just to lose the weight.

What if instead of referring them out or watching helplessly, you could offer them the treatment that’s changing lives — GLP-1 medications like semaglutide and tirzepatide?

The numbers tell the story: roughly 6% of Americans (20 million people) were taking GLP-1 drugs by late 2025, with half using them specifically for weight loss — a 600% increase in obesity use over just six years. Meanwhile, a late-2023 survey found that nearly half of psychiatrists were already prescribing or recommending these medications, often to address medication-induced weight gain.

This isn’t a side hustle. It’s a legitimate expansion of psychiatric care that addresses a massive, underserved need. And if you structure it right, you can scale this service line to meet exploding patient demand without adding to your burnout.

Here’s what psychiatrists actually need to know about building a sustainable GLP-1 practice.

Why Psychiatrists Are Uniquely Positioned for GLP-1 Care

Unlike primary care docs juggling 30 patients a day or endocrinologists focused purely on metabolic parameters, psychiatrists bring something different to weight management: expertise in behavior change and mental health.

Weight loss isn’t just about the medication. It’s about addressing the emotional eating, the shame spiral after binges, the motivation that tanks at month three, the body image issues that persist even after losing 40 pounds. You already know how to navigate these conversations. You’re trained in motivational interviewing, managing treatment resistance, and supporting patients through long-term behavioral change.

Plus, you’re already managing the psychiatric medications that cause the weight gain in the first place. When a patient on olanzapine or mirtazapine asks about weight loss, you can offer integrated care instead of a referral that may never happen. You can monitor both their mental health and their metabolic health, catching potential mood changes that other providers might miss.

Some early research even suggests GLP-1s might independently improve certain psychiatric symptoms — though the jury’s still out, and you should absolutely monitor for the rare reports of mood changes that prompted (and later led to removal of) FDA warnings about suicidal ideation.

The point: you’re not stepping outside your lane. You’re expanding it to treat the whole patient.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

The Market Reality: High Demand, Low Provider Supply

Let’s talk numbers. Nearly 75% of Americans are overweight or obese. Traditional obesity medicine specialists can’t come close to meeting demand — tens of thousands of new patients start GLP-1 treatments every week, and many lack access to specialized obesity clinics.

This creates opportunity. Real opportunity.

Patients are actively seeking providers who can prescribe these medications. Google searches for ‘semaglutide near me’ and ‘Ozempic doctor’ are through the roof. And unlike some telehealth trends that fizzled post-pandemic, GLP-1 demand continues to surge as more people see real results.

But here’s where most psychiatrists get stuck: patient acquisition.

How to Actually Get GLP-1 Patients (Without Wasting Money)

Let’s be honest about the economics. You’ll see advice online suggesting you can acquire patients for $30-50 through DIY marketing. That’s fantasy.

Reality check on patient acquisition costs:

• SEO takes 6-12 months of consistent investment before generating meaningful patient flow. You need keyword research, ongoing content creation, technical optimization, and backlink building. Most solo providers don’t have the expertise, time, or patience.

• Google Ads for mental health and weight-loss keywords run $15-40+ per click. Most clicks don’t convert to booked patients. A realistic cost per booked patient through PPC is $200-400+ when you factor in testing, optimization, and click-through rates.

• Directory listings (Psychology Today, Zocdoc) charge monthly fees AND you compete with hundreds of other providers on the same page. Zocdoc charges per booking, and while individual booking fees vary, your total monthly cost including subscriptions adds up fast.

When you factor in ALL costs — agency/consultant fees, ad spend, staff time to handle and qualify leads, no-show rates from cold leads, months of testing before results, and flat-out failed campaigns — acquiring a qualified psychiatric patient through DIY marketing typically costs $200-500+.

Smarter approaches:

1. Start with your existing patients
Identify current patients with BMI ≥30 (or ≥27 with comorbidities) and discuss weight-loss options during medication reviews. Many would welcome help with weight gain; introducing GLP-1 therapy when discussing side effect management or medication adjustments is natural and builds on established trust. Zero additional marketing cost.

2. Join a telehealth platform
Platforms like Klarity Health use a pay-per-appointment model where you pay a standard listing fee per new patient lead — but critically, only when a qualified patient actually books with you. No upfront marketing spend. No monthly subscription fees eating into your budget. No wasted ad spend on clicks that don’t convert.

The patients are pre-qualified and already matched to your specialty and availability. The platform handles the infrastructure (telehealth tech, patient acquisition, scheduling). You control your schedule and pay only when you see patients.

Frame it economically: Instead of gambling $3,000-5,000/month on marketing with uncertain ROI, you pay only when a qualified patient shows up. That’s guaranteed economics vs. the risk of DIY channels that may or may not work.

Can DIY marketing eventually be cost-effective? Sure — IF you have the budget, expertise, and patience to test and optimize for months. But for most providers, especially those starting out or scaling quickly, a platform that handles patient acquisition removes the financial risk entirely.

3. Strategic referral relationships
Build relationships with PCPs, endocrinologists, bariatric surgeons, therapists, and dietitians. These professionals encounter obese patients who could benefit from GLP-1s but lack bandwidth for ongoing weight management. Emphasize that you’ll update them on patient progress and refer back for routine care. A brief email or lunch meeting can yield steady referrals.

Telehealth Compliance: The State-by-State Reality

GLP-1 medications are not controlled substances, which means you can prescribe them via telehealth without Ryan Haight Act restrictions. No in-person exam required federally.

But state rules matter. A lot.

Licensure Requirements

You must be licensed in the patient’s state. Period. Some key considerations:

For Psychiatrists (MD/DO):

• IMLC states (Texas, Pennsylvania, Illinois, and others) allow expedited multi-state licensure through the Interstate Medical Licensure Compact
• California and New York are NOT in the IMLC — you need full state licensure
• Florida offers an out-of-state telehealth provider registration that lets you practice telemedicine without full Florida licensure (with some controlled substance restrictions that don’t affect GLP-1s)

For Psychiatric NPs (PMHNPs):

This gets more complex. Your prescriptive authority varies dramatically by state:

If you’re a PMHNP in a restricted state (Texas, Pennsylvania), you’ll need to partner with a supervising psychiatrist or physician. Many telehealth platforms handle this arrangement, pairing NPs with MDs who provide the required oversight.

State-Specific Telehealth Rules

Beyond licensure, watch for these state requirements:

• California: Must obtain patient consent (verbal or written) for telehealth and document it
• Texas: Can establish patient relationship via telemedicine (no in-person visit required) as long as adequate evaluation is performed. Allows audio-only for mental health, but requires video for weight-loss evaluations
• Florida: No in-person exam required. Adequate telehealth evaluation meets standard of care
• New York: Telehealth parity law requires insurers to cover telehealth like in-person. No special restrictions beyond standard practice
• Pennsylvania: No blanket in-person requirement for non-controlled substances. Adequate video evaluation acceptable
• Illinois: Comprehensive telehealth parity law (2021). Explicitly permits telehealth to establish patient relationship

Standard of Care: What ‘Adequate Evaluation’ Actually Means

When using semaglutide (Ozempic) or tirzepatide for weight loss, you’re often prescribing off-label (Wegovy is the FDA-approved brand for obesity). This is legal but requires proper documentation.

Your initial evaluation should include:

• Comprehensive weight history (previous attempts, yo-yo dieting patterns)
• Medical history screening for contraindications (history of medullary thyroid carcinoma, pancreatitis, gastroparesis)
• Current medications and psychiatric stability
• BMI calculation and documentation of qualifying criteria (≥30, or ≥27 with comorbidities)
• Mental health screening (binge eating disorder, emotional eating patterns, body image issues)
• Baseline labs: A1c, fasting glucose, liver enzymes, TSH (if indicated)
• Diet and exercise assessment
• Clear discussion of realistic expectations, side effects, and need for lifestyle changes
• Informed consent for off-label use (if applicable)

Ongoing monitoring: Patients need at least monthly follow-ups during dose escalation to track weight loss, adjust doses, manage side effects (nausea, constipation), and provide behavioral support. Once stable, you can space visits to every 2-3 months.

Document everything. Template notes save time while ensuring you hit all required elements.

The Cash vs. Insurance Decision

Most telehealth GLP-1 practices favor cash-pay models, and for good reason.

Insurance reality: While most insurers cover GLP-1 drugs for diabetes, coverage for obesity is limited. As of mid-2024, only 13 state Medicaid programs (including California and Pennsylvania) covered GLP-1s for weight loss. Many private plans explicitly exclude them.

This creates a market where patients expect to pay out-of-pocket for medication anyway — often $200-500/month for compounded semaglutide, or $1,300+ for brand-name Wegovy without insurance.

Cash-Pay Model

Pros:

• Simpler operations (no prior authorizations, no denials to fight)
• Direct revenue (patients pay for consults and meds)
• Pairs naturally with patients’ reality that medications are often out-of-pocket
• Clear pricing patients appreciate

Typical structure: Monthly subscription ($99-199) covering consultations, check-ins, and support, plus separate medication costs. Or per-visit fees ($150-300 for initial, $75-150 for follow-ups).

Cons:

• Limits access for lower-income patients
• May miss patients who only seek insurance-covered care

Insurance Model

Pros:

• Wider patient access
• Can bill E/M codes for obesity counseling/management
• In states with Medicaid coverage (CA, PA, IL), taps into underserved population

Cons:

• Prior authorization hell for medications (even when visit is covered)
• Lower reimbursement rates
• Documentation burden
• Denials to appeal

Medicare note: In late 2025, Medicare announced plans to pilot covering weight-loss drugs. If this expands, insurance-based models may become more viable.

The Hybrid Approach

Many successful practices charge cash for initial evaluations (which involve lengthy assessment and education not fully reimbursed by insurance), then offer patients the choice of insurance or cash for follow-ups based on their coverage.

Be transparent: Clearly outline what’s cash vs. billed, help patients estimate monthly medication costs, and explain that medication coverage varies wildly by plan.

Scaling Without Burning Out: The Workflow Reality

Here’s the truth: if you handle every intake, every follow-up, every dietary question, and every ‘Is nausea normal?’ message yourself, you’ll burn out fast.

Scaling a GLP-1 practice requires systems and delegation.

Streamline Intake

Before the first appointment:

• Digital intake forms gathering comprehensive history (weight history, medical conditions, medications, mental health status, diet/exercise patterns)
• Patient portal uploads of recent labs if available
• Educational materials about GLP-1s sent automatically

Create protocols:

• Standardized ‘Obesity Intake Panel’ lab orders (one-click)
• Clinical checklists ensuring each initial consult covers nutrition, exercise, goal-setting, medication teaching, mental health screening
• Template documentation hitting all required elements

This lets you focus on clinical judgment rather than hunting for information during appointments.

Delegate Non-Specialist Tasks

Medical assistants or RNs can:

• Gather interim data (weights, blood pressure, symptom questionnaires) before visits
• Handle routine patient questions via portal messaging using approved scripts
• Provide injection technique training
• Send medication refill reminders
• Track lab completion and follow-up

Health coaches or dietitians can:

• Conduct biweekly check-ins on diet and exercise adherence
• Lead monthly group support sessions (addressing common struggles, sharing wins)
• Provide meal planning resources
• Handle lifestyle counseling between your appointments

You focus on: Medication decisions, dose adjustments, complex clinical issues, mental health integration, and patients who aren’t responding as expected.

Optimize Follow-Up Cadence

Intensive phase (months 1-6):

• Provider visit at months 1, 3, 5 for medication management
• Coach/RN check-ins at months 2, 4, 6 for adherence and side effects
• Monthly group support sessions (optional but boost retention)

Maintenance phase (month 6+):

• Provider visits every 2-3 months
• As-needed messaging for issues
• Quarterly group sessions
• Annual labs

Leverage Technology

Essential tools:

• Telehealth platform with integrated video, e-prescribing, and messaging (reduces administrative friction)
• Automated appointment reminders and online scheduling
• Template documentation (saves 5-10 minutes per note)
• Patient portal with educational resources and FAQs

Nice-to-have:

• Connected scales or apps for patient weight tracking (you can review trends at a glance)
• Automated messages triggered by prescription fills (‘Starting dose? Here’s what to expect…’)
• AI chatbots handling routine FAQs

Result: Follow-ups become 15-20 minute focused sessions on progress and adjustments, not 40-minute sessions gathering basic info.

Set Boundaries to Protect Yourself

Start gradually: Maybe 1-2 half-days per week dedicated to weight-loss patients initially. Test your workflows before scaling.

Define availability: Set firm hours for patient messaging. Use delayed send features or an answering service after-hours. Just because you’re doing telehealth doesn’t mean you’re available 24/7.

Mix your practice: Many psychiatrists maintain both psychiatric and weight-management patients for variety and to keep skills sharp in both areas. Others transition entirely. Either works — just be intentional.

Monitor burnout signs: Emotional exhaustion, depersonalization, declining performance. If these appear, temporarily cap new patient intake or hire additional providers to share the load.

Invest in support: The cost of a part-time RN, health coach, or virtual assistant pays for itself in your capacity to see more patients without overwhelm.

Build Team-Based Care

Consider a group practice model: You (the prescribing psychiatrist) handle initial evaluations and complex cases. Employed or contracted PMHNPs (in appropriate states) or PAs handle routine follow-ups under your supervision.

This mirrors successful psychiatric clinic models and scales both your impact and revenue without proportionally increasing your hours.

The Bottom Line: A Real Opportunity, Done Right

The GLP-1 weight-loss market isn’t hype — it’s a genuine shift in how obesity is treated, and patient demand far exceeds provider supply.

As a psychiatrist, you bring unique value: understanding of behavior change, expertise in mental health, existing relationships with patients who need this care, and telehealth experience that positions you perfectly for this work.

But building a sustainable practice requires realistic economics (don’t fall for $50 patient acquisition fantasies), solid compliance with state regulations (especially if you’re an NP), proper clinical protocols (this is medical care, not a side gig), and most critically, systems that prevent burnout.

Start small. Build your workflows. Delegate what you can. Use platforms that handle patient acquisition so you’re not gambling thousands on marketing. Monitor your own well-being as closely as your patients’ progress.

Done right, you can scale a GLP-1 practice that generates significant revenue, helps patients transform their lives, and integrates seamlessly with your psychiatric expertise — all without burning out.

The patients are out there, searching for providers right now. The question is whether you’re going to meet them where they are.

Ready to connect with pre-qualified GLP-1 patients without the marketing gamble? Klarity Health’s platform matches you with patients actively seeking weight-loss care, handles the telehealth infrastructure, and operates on a pay-per-appointment model — you only pay when patients actually book. No upfront costs. No monthly subscriptions. Just qualified patients and guaranteed ROI. Learn more about joining Klarity’s provider network.

FAQ

Can psychiatrists legally prescribe GLP-1 medications for weight loss?

Yes. Psychiatrists (MD/DO) have full prescriptive authority for these medications in all states. GLP-1 agonists are not controlled substances, so you can prescribe them via telehealth without Ryan Haight Act restrictions. When prescribing semaglutide (Ozempic) or tirzepatide off-label for obesity, document appropriate medical necessity (BMI ≥30 or ≥27 with comorbidities) and obtain informed consent.

Do I need a special certification to offer weight-loss services?

No special certification is required. However, pursuing obesity medicine CME or certification through the American Board of Obesity Medicine (ABOM) can boost your confidence, improve clinical outcomes, and differentiate your practice in marketing. It’s not legally required, but it’s valuable professional development.

Can PMHNPs prescribe GLP-1s independently?

It depends on your state. New York and Illinois allow experienced NPs (after 3,600-4,000 practice hours) to prescribe independently. California will allow it starting 2026 for qualified NPs. Texas, Pennsylvania, and Florida require physician collaboration agreements for NP prescribing. Check your specific state’s APRN scope of practice laws.

What’s a realistic patient load for a solo psychiatrist adding GLP-1 services?

Starting conservatively, 1-2 half-days weekly can handle 20-30 active GLP-1 patients (considering initial consults take 45-60 minutes, follow-ups 15-20 minutes). With strong workflows and delegation to support staff, you could scale to 100+ patients while maintaining quality care. Monitor your capacity and add team members before you’re overwhelmed.

How much can I realistically earn from a GLP-1 practice?

Revenue varies based on cash vs. insurance, patient volume, and pricing. Cash-pay example: 50 active patients paying $150/month subscription = $7,500/month gross. Deduct platform fees (if using one), staff costs, and overhead. Insurance reimbursement is lower per visit but predictable. Many providers generate $5,000-15,000+ monthly from GLP-1 services once established, with higher revenue as you scale.

What are the most common side effects patients ask about?

Nausea (especially early on), constipation, injection site reactions, and fatigue. Less common: gastroparesis, gallbladder issues. Rare but serious: pancreatitis, thyroid tumors (contraindicated in patients with personal/family history of medullary thyroid carcinoma). Have protocols for managing common issues so you’re not reinventing the wheel each time.

Should I partner with a compounding pharmacy or use brand-name medications?

Both have trade-offs. Brand-name (Wegovy, Saxenda) ensures FDA oversight and consistent dosing but costs $1,300+ monthly without insurance. Compounded semaglutide from licensed 503B pharmacies costs $200-500 monthly and expands access, but you must vet pharmacy quality carefully (the FDA has warned about unregulated compounders). Many practices offer both options and let patients choose based on budget.

How do I handle patients who plateau or don’t lose weight?

This happens. Plateau management includes: dose titration (if not at maximum), reviewing diet and exercise adherence (often the issue), screening for medications causing weight gain, checking thyroid function, and addressing behavioral factors (stress eating, sleep issues). Sometimes switching from semaglutide to tirzepatide helps. Set realistic expectations upfront: GLP-1s are powerful tools but not magic, and weight loss varies individually. Document your clinical reasoning for any changes.

References

1. Axios – ‘Just how many Americans are taking GLP-1s now’ (Fair Health data on usage), May 27, 2025. Available at: https://www.axios.com/2025/05/27/american-glp1-use-weight-loss-increasing

2. ConfectioneryNews – ‘GLP-1 drugs like Ozempic are reshaping health, diet and the food industry,’ October 20, 2025. Available at: https://www.confectionerynews.com/Article/2025/10/20/glp-1-drugs-like-ozempic-are-reshaping-health-diet-and-the-food-industry/

3. Time Magazine – ‘The Heavy Cost of Using Weight-Loss Drugs to Get Skinny,’ August 22, 2025. Available at: https://time.com/7311517/cost-weight-loss-drugs-skinny/

4. Axios – ‘America’s doctors need more obesity medicine training,’ May 28, 2024. Available at: https://www.axios.com/2024/05/28/us-doctors-obesity-health-care-training

5. Axios – ‘States slow to cover GLP-1s for weight loss’ (KFF policy report), November 5, 2024. Available at: https://www.axios.com/2024/11/05/states-slow-to-cover-glp-1s-for-weight-loss

Source:

• https://www.axios.com/2025/05/27/american-glp1-use-weight-loss-increasing#:~:text=More%20than%202,their%20original%20approved%20use
• https://www.confectionerynews.com/Article/2025/10/20/glp-1-drugs-like-ozempic-are-reshaping-health-diet-and-the-food-industry/#:~:text=GLP,real%20number%20according%20to%20Kim
• https://forum.schizophrenia.com/t/psychiatrists-recommend-ozempic/311318#:~:text=Drugs%20pharmanewsintel
• https://www.medicaldirectorco.com/texas-weight-loss-clinic-telehealth-compliance-guide/#:~:text=equivalent%20to%20in,FDA%2C%20pharmacy%2C%20and%20board%20alerts
• https://www.medicaldirectorco.com/texas-weight-loss-clinic-telehealth-compliance-guide/#:~:text=,with%20chart%20review%2C%20plus%20meetings
• https://www.singleaimhealth.com/news/nurse-practitioner-collaborative-agreement-templates-50-state-guide#:~:text=In%20Pennsylvania%2C%20Certified%20Registered%20Nurse,the%20CRNP%20and%20the%20collaborating
• https://www.wheel.com/state-telehealth-regulations/florida#:~:text=Are%20There%20Online%20Prescription%20Restrictions,for%20Telehealth%20in%20Florida
• https://time.com/7311517/cost-weight-loss-drugs-skinny/#:~:text=most%20insurances%20cover%20the%20medication,A%20recent%20Annals%20of%20Internal
• https://www.axios.com/2024/11/05/states-slow-to-cover-glp-1s-for-weight-loss#:~:text=What%20they%20found%3A%20In%20all%2C,a%20primary%20concern%2C%20KFF%20found
• https://time.com/7311517/cost-weight-loss-drugs-skinny/#:~:text=But%20these%20medications%20were%20originally,diabetes%2C%20weight%20loss%20treatment%20is